CAR-NK cells are allogeneic effector cells that can be easily expanded and modified, which can enhance the universality and simplicity of treatment, and make up for the weakness of autoimmune cells in patients with advanced cancer. Cell Valley provides R&D and outsourcing production services for
CAR-NK cells with different targets.